Harold P Adams1. 1. Division of Cerebrovascular Diseases, Department of Neurology, Carver College of Medicine, University of Iowa Hospitals and Clinics, University of Iowa, 200 Hawkins Drive, Iowa City, IA, 52242, USA. harold-adams@uiowa.edu.
Abstract
PURPOSE OF REVIEW: To review the latest information about the interactions between cancer and cerebrovascular disease. RECENT FINDINGS: Additional data support the finding that both ischemic and hemorrhagic stroke are important complications of cancer or its treatment. Reperfusion therapy is being given successfully to patients with stroke complicating cancer. Hemorrhagic stroke may occur with metastatic disease to the brain, coagulopathies from cancer, in particular leukemia, or as complications of chemotherapy. Ischemic stroke also may be a complication of metastatic disease with local invasion of vessels, a pro-thrombotic disorder such as non-bacterial thrombotic endocarditis (NBTE) or disseminated intravascular coagulation (DIC), or secondary to chemotherapy. Stroke also is a potential consequence of radiation therapy to the head and neck. Venous sinus thrombosis may develop with hematologic malignancies or chemotherapy. Although many patients will have a history of cancer at the time of stroke, a cerebrovascular event may be the initial manifestation of a malignancy.
PURPOSE OF REVIEW: To review the latest information about the interactions between cancer and cerebrovascular disease. RECENT FINDINGS: Additional data support the finding that both ischemic and hemorrhagic stroke are important complications of cancer or its treatment. Reperfusion therapy is being given successfully to patients with stroke complicating cancer. Hemorrhagic stroke may occur with metastatic disease to the brain, coagulopathies from cancer, in particular leukemia, or as complications of chemotherapy. Ischemic stroke also may be a complication of metastatic disease with local invasion of vessels, a pro-thrombotic disorder such as non-bacterial thrombotic endocarditis (NBTE) or disseminated intravascular coagulation (DIC), or secondary to chemotherapy. Stroke also is a potential consequence of radiation therapy to the head and neck. Venous sinus thrombosis may develop with hematologic malignancies or chemotherapy. Although many patients will have a history of cancer at the time of stroke, a cerebrovascular event may be the initial manifestation of a malignancy.
Authors: N I Weijl; M F Rutten; A H Zwinderman; H J Keizer; M A Nooy; F R Rosendaal; F J Cleton; S Osanto Journal: J Clin Oncol Date: 2000-05 Impact factor: 44.544
Authors: Daniel C Bowers; Yan Liu; Wendy Leisenring; Elizabeth McNeil; Marilyn Stovall; James G Gurney; Leslie L Robison; Roger J Packer; Kevin C Oeffinger Journal: J Clin Oncol Date: 2006-11-06 Impact factor: 50.717
Authors: Barrett D Allen; Munjal M Acharya; Pierre Montay-Gruel; Patrik Goncalves Jorge; Claude Bailat; Benoît Petit; Marie-Catherine Vozenin; Charles Limoli Journal: Radiat Res Date: 2020-12-01 Impact factor: 2.841
Authors: Guillaume Lamotte; Elizabeth A Coon; Mariana D Suarez; Paola Sandroni; Eduardo E Benarroch; Jeremy K Cutsforth-Gregory; Michelle L Mauermann; Sarah E Berini; Kamal Shouman; David Sletten; Brent P Goodman; Phillip A Low; Wolfgang Singer Journal: Neurology Date: 2021-05-04 Impact factor: 11.800